Melecular Cytology
分子细胞学
基本信息
- 批准号:8933517
- 负责人:
- 金额:$ 46.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Molecular Cytology Core Facility (MCCF) underpins all the basic and clinical research at MSKCC
involving the interrogation of proteins or nucleic acids in cells, tissues and tumors. The MCCF retains state-of-
the-art equipment and an array of imaging tools and a team of highly talented technical assistants and as
such provides both a service and one-on-one training enabling faculty and their trainees to work
independently with high-end instrumentation. A resource of validated antibodies for automated or manual
histology is a feature of the Core's rapid and reliable service used by investigators working with animal tumor
models or patient samples. To explore the cell biology of cancer cells at high spatial and temporal
resolution, the Core's in-house expertise enables the power of a superb suite of confocal microscopes to be
accessible not only to cell biologists but also to the wider community of members of the Cancer Center.
Imaging modalities for molecular detection available to the researchers at the MCCF are optical
microscopes, including wide field (epifluorescence, bright field, polarizing and DIC), confocal (raster
scanning, line scanning and spinning disc), time lapse microscopy, FLIM and digital scanners. Experiments
involving uncaging experiments, FRAP and FRET, and Ratio imaging of calcium ions are also carried out at
the MCCF. In addition to assistance and training on image acquisition, the MCCF staff provide assistance to
researchers in image processing and analysis using Velocity, MetaMorph, Imaris and MatLab software. The
broad range of services and collaborative work provided by the Molecular Cytology Core has supported the
research of 120 investigators in the past year. During the past grant period the work of the Core has
contributed to 315 publications of researchers from 5 research programs. For example, with the assistance
of the Core, Studer and Tabar demonstrated that neural rosette cells represent the first characterized neural
stem cell stage capable of responding to patterning cues that direct differentiation toward region-specific
neuronal fates. The Core provided immunohistochemistry and image analysis critical to this work.
分子细胞学核心设施(MCCF)为MSKCC的所有基本和临床研究的基础
涉及细胞,组织和肿瘤中蛋白质或核酸的询问。 MCCF保留
Art设备和一系列成像工具以及一支由才华横溢的技术助理组成的团队
这样的服务提供了服务和一对一的培训,使教师及其学员可以工作
独立使用高端仪器。自动或手册的经过验证抗体的资源
组织学是核心快速可靠的服务的特征
模型或患者样品。探索在高空间和时间上的癌细胞的细胞生物学
解决方案,核心的内部专业知识使精湛的共聚焦显微镜的力量能够成为
不仅可以访问细胞生物学家,而且可以访问癌症中心成员的更广泛社区。
MCCF研究人员可用于分子检测的成像方式是光学的
显微镜,包括宽场(落荧光,明亮场,偏振和DIC),共焦(栅格
扫描,线条扫描和旋转盘),延时显微镜,FLIM和数字扫描仪。实验
还涉及分离实验,FRAP和FRET以及钙离子的比率成像
MCCF。除了获得图像获取的协助和培训外,MCCF的工作人员还为
使用速度,Metamorph,Imaris和Matlab软件进行图像处理和分析的研究人员。这
分子细胞学核心提供的广泛服务和协作工作已支持
过去一年对120名调查人员的研究。在过去的赠款期间,核心的工作已经
为5个研究计划的315名研究人员出版物做出了贡献。例如,在协助下
在核心中,Studer和Tabar证明了神经玫瑰花塞细胞代表了第一个特征的神经
干细胞阶段,能够响应直接分化为特定区域的图案提示
神经元的命运。核心提供了对这项工作至关重要的免疫组织化学和图像分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
katia Ognianova ma...的其他基金
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure
m6A-RNA 甲基化在记忆形成和回忆中的作用及其对早期铅暴露对长期结果的影响
- 批准号:1065802010658020
- 财政年份:2023
- 资助金额:$ 46.06万$ 46.06万
- 项目类别:
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes
多价 Tau 和 A-Beta 肽在免疫原性 SNAP 脂质体上的马赛克展示
- 批准号:1069937010699370
- 财政年份:2023
- 资助金额:$ 46.06万$ 46.06万
- 项目类别:
Characterization of novel pyrazole compounds with potent anti-cancer activity
具有有效抗癌活性的新型吡唑化合物的表征
- 批准号:1062754310627543
- 财政年份:2023
- 资助金额:$ 46.06万$ 46.06万
- 项目类别:
IgG and FcR Characterization in Small Animal Models of RespiratoryDisease
呼吸道疾病小动物模型中的 IgG 和 FcR 表征
- 批准号:1067822910678229
- 财政年份:2023
- 资助金额:$ 46.06万$ 46.06万
- 项目类别:
Core 3: Biocontainment Research Support Services Core
核心 3:生物防护研究支持服务核心
- 批准号:1079195010791950
- 财政年份:2023
- 资助金额:$ 46.06万$ 46.06万
- 项目类别: